The impact of personal experiences with infection and vaccination on behaviour-incidence dynamics of seasonal influenza.

Personal experiences with past infection events, or perceived vaccine failures and complications, are known to drive vaccine uptake. We coupled a model of individual vaccinating decisions, influenced by these drivers, with a contact network model of influenza transmission dynamics. The impact of non-influenzal influenza-like illness (niILI) on decision-making was also incorporated: it was possible for individuals to mistake niILI for true influenza. Our objectives were to (1) evaluate the impact of personal experiences on vaccine coverage; (2) understand the impact of niILI on behaviour-incidence dynamics; (3) determine which factors influence vaccine coverage stability; and (4) determine whether vaccination strategies can become correlated on the network in the absence of social influence. We found that certain aspects of personal experience can significantly impact behaviour-incidence dynamics. For instance, longer term memory for past events had a strong stabilising effect on vaccine coverage dynamics, although it could either increase or decrease average vaccine coverage depending on whether memory of past infections or past vaccine failures dominated. When vaccine immunity wanes slowly, vaccine coverage is low and stable, and infection incidence is also very low, unless the effects of niILI are ignored. Strategy correlations can occur in the absence of imitation, on account of the neighbour-neighbour transmission of infection and history-dependent decision making. Finally, niILI weakens the behaviour-incidence coupling and therefore tends to stabilise dynamics, as well as breaking up strategy correlations. Behavioural feedbacks, and the quality of self-diagnosis of niILI, may need to be considered in future programs adopting "universal" flu vaccines conferring long-term immunity. Public health interventions that focus on reminding individuals about their previous influenza infections, as well as communicating facts about vaccine efficacy and the difference between influenza and niILI, may be an effective way to increase vaccine coverage and prevent unexpected drops in coverage.

[1]  Marcel Salathé,et al.  Assessing Vaccination Sentiments with Online Social Media: Implications for Infectious Disease Dynamics and Control , 2011, PLoS Comput. Biol..

[2]  C. Watkins,et al.  The spread of awareness and its impact on epidemic outbreaks , 2009, Proceedings of the National Academy of Sciences.

[3]  T. Jefferson,et al.  Vaccines for preventing influenza in healthy adults. , 2000, The Cochrane database of systematic reviews.

[4]  R B Couch,et al.  Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.

[5]  G. Chapman,et al.  Emotions and preventive health behavior: worry, regret, and influenza vaccination. , 2006, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[6]  Joel Huber,et al.  Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults , 2002, Annals of Internal Medicine.

[7]  M. Keeling,et al.  The effects of local spatial structure on epidemiological invasions , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[8]  L E Rodewald,et al.  Effect of patient reminder/recall interventions on immunization rates: A review. , 2000, JAMA.

[9]  Evan W. Orenstein,et al.  Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. , 2007, International journal of epidemiology.

[10]  B. Perkins,et al.  Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[11]  J. Kaiser.  A One-Size-Fits-All Flu Vaccine? , 2006, Science.

[12]  M. H. Merrill,et al.  Attitudes and Reactions of the Public to Health Programs: II. Attitudes of Californians Toward Poliomyelitis Vaccination , 1958 .

[13]  M. Meltzer,et al.  Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. , 2000, JAMA.

[14]  S. Blower,et al.  A universal long-term flu vaccine may not prevent severe epidemics , 2010, BMC Research Notes.

[15]  Cecile Viboud,et al.  Vaccinating to Protect a Vulnerable Subpopulation , 2007, PLoS medicine.

[16]  K. Nichol,et al.  Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. , 2001, Archives of internal medicine.

[17]  Samit Bhattacharyya,et al.  Evolutionary Game Theory and Social Learning Can Determine How Vaccine Scares Unfold , 2012, PLoS Comput. Biol..

[18]  Julie Gilchrist,et al.  "Choking game" awareness and participation among 8th graders--Oregon, 2008. , 2010, MMWR. Morbidity and mortality weekly report.

[19]  W. Fiers,et al.  A "universal" human influenza A vaccine. , 2004, Virus research.

[20]  R. Cox,et al.  Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines , 2004, Scandinavian journal of immunology.

[21]  A David Paltiel,et al.  Economic costs of influenza-related work absenteeism. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[22]  T. Szucs.  The socio-economic burden of influenza. , 1999, The Journal of antimicrobial chemotherapy.

[23]  Zhipeng Qiu,et al.  Transmission Dynamics of an Influenza Model with Vaccination and Antiviral Treatment , 2010, Bulletin of mathematical biology.

[24]  D. Rand,et al.  Correlation models for childhood epidemics , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[25]  J. Kaldor,et al.  Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[26]  Cecile Viboud,et al.  Prioritization of influenza pandemic vaccination to minimize years of life lost. , 2008, The Journal of infectious diseases.

[27]  G. Chapman,et al.  Predictors of influenza vaccine acceptance among healthy adults. , 1999, Preventive medicine.

[28]  R. Walker,et al.  Duration of Protection Provided by Live Attenuated Influenza Vaccine in Children , 2008, The Pediatric infectious disease journal.

[29]  L. Meyers.  Contact network epidemiology: Bond percolation applied to infectious disease prediction and control , 2006 .

[30]  D. Fleming,et al.  Diagnosis and patterns of incidence of influenza, influenza-like illness and the common cold in general practice. , 1988, The Journal of the Royal College of General Practitioners.

[31]  Lauren Ancel Meyers,et al.  Erratic Flu Vaccination Emerges from Short-Sighted Behavior in Contact Networks , 2011, PLoS Comput. Biol..

[32]  D. Earn,et al.  Vaccination and the theory of games. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Bridges,et al.  The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.

[34]  Sébastien Ballesteros,et al.  The role of weather on the relation between influenza and influenza-like illness. , 2012, Journal of theoretical biology.

[35]  Jacco Wallinga,et al.  Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. , 2008, Vaccine.

[36]  C. Bauch,et al.  Erratum to: Impact of Imitation Processes on the Effectiveness of Ring Vaccination , 2014, Bulletin of Mathematical Biology.

[37]  P. J. Ryan,et al.  The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. , 1998, Occupational medicine.

[38]  C. Bauch.  Imitation dynamics predict vaccinating behaviour , 2005, Proceedings of the Royal Society B: Biological Sciences.

[39]  L. Rosella,et al.  Trends in influenza vaccination in Canada, 1996/1997 to 2005. , 2007, Health reports.

[40]  M E Halloran,et al.  Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. , 2000, Vaccine.

[41]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[42]  Ana Perisic,et al.  Social Contact Networks and Disease Eradicability under Voluntary Vaccination , 2009, PLoS Comput. Biol..

[43]  Jonathan Dushoff,et al.  Ecology and evolution of the flu , 2002 .

[44]  Piero Poletti,et al.  Spontaneous behavioural changes in response to epidemics. , 2009, Journal of theoretical biology.

[45]  M. Meltzer,et al.  The economic impact of pandemic influenza in the United States: priorities for intervention. , 1999, Emerging infectious diseases.

[46]  S. Ribeiro,et al.  T-SPOT.TB responses during treatment of pulmonary tuberculosis , 2009, BMC infectious diseases.

[47]  Mark A. Miller,et al.  Spatial and Temporal Characteristics of the 2009 A/H1N1 Influenza Pandemic in Peru , 2011, PloS one.

[48]  Timothy C. Reluga,et al.  Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum , 2007, Proceedings of the National Academy of Sciences.

[49]  S C Schoenbaum,et al.  Economic Impact of Influenza: The Individual's Perspective , 1987, The American journal of medicine.

[50]  Chris T Bauch,et al.  A simulation analysis to characterize the dynamics of vaccinating behaviour on contact networks , 2009, BMC infectious diseases.

[51]  Richard B. Brown,et al.  Complications of Viral Influenza , 2008, The American Journal of Medicine.

[52]  Daniel I. S. Rosenbloom,et al.  Imitation dynamics of vaccination behaviour on social networks , 2011, Proceedings of the Royal Society B: Biological Sciences.

[53]  Yvonne Bordon.  Flu vaccine surplus , 2010, Nature Reviews Immunology.

[54]  J. Kaiser.  Facing Down Pandemic Flu, the World's Defenses Are Weak , 2004, Science.

[55]  Joel C. Miller,et al.  Epidemic size and probability in populations with heterogeneous infectivity and susceptibility. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.

[56]  H. Andersson,et al.  Epidemics in a population with social structures. , 1997, Mathematical biosciences.

[57]  M. Salathé,et al.  The effect of opinion clustering on disease outbreaks , 2008, Journal of The Royal Society Interface.

[58]  D. Fedson.  Pandemic influenza and the global vaccine supply. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  Timothy C. Reluga,et al.  Evolving public perceptions and stability in vaccine uptake. , 2006, Mathematical biosciences.

[60]  J. Treanor.  Influenza vaccine--outmaneuvering antigenic shift and drift. , 2004, The New England journal of medicine.

[61]  R. Couch.  Advances in Influenza Virus Vaccine Research a , 1993, Annals of the New York Academy of Sciences.

[62]  M Elizabeth Halloran,et al.  Population-wide benefits of routine vaccination of children against influenza. , 2005, Vaccine.